Skip to main content
. 2021 Nov 22;25(2):54–62. doi: 10.1136/ebmental-2021-300311

Table 2.

HRs and 95% CIs comparing the risk for ADHD in exposed and unexposed children by timing and type of antipsychotic exposure

Number with ADHD/N Person-years at risk Hazard ratio (95% CI)
Crude Model 1* Model 2†
Antipsychotic exposure
 Unexposed 71775/4 308 620 41 863 339 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
 Exposed anytime during pregnancy 482/15 466 130 211 2.28 (2.08 to 2.49) 2.00 (1.83 to 2.19) 1.10 (1.00 to 1.21)
Timing of antipsychotic exposure
 First trimester only 210/6478 56 144 2.17 (1.90 to 2.49) 1.72 (1.51 to 1.97) 1.07 (0.93 to 1.23)
 Second/third trimester only 103/3349 28 534 2.24 (1.84 to 2.72) 2.09 (1.72 to 2.54) 1.08 (0.89 to 1.32)
 First trimester and second/third trimester 169/5639 45 534 2.45 (2.10 to 2.85) 2.46 (2.11 to 2.85) 1.06 (0.90 to 1.25)
Type of antipsychotic exposure
 Typical antipsychotics only 272/6896 75 179 1.84 (1.63 to 2.08) 1.71 (1.51 to 1.93) 1.11 (0.98 to 1.26)
 Atypical antipsychotics only 166/7752 48 100 3.11 (2.67 to 3.62) 2.40 (2.06 to 2.79) 1.00 (0.85 to 1.17)

*Adjusted for source country, birth year, sex of child, maternal age, and parity.

†Adjusted for source country, birth year, sex of child, maternal age, parity, maternal education, cohabitation, mother born within source country, BMI, smoking, maternal comorbidity, use of known teratogens, use of suspected teratogens, other medications during pregnancy.

ADHD, attention-deficit/hyperactivity disorder; BMI, body mass index; CI, confidence interval; HR, hazard ratio.